Vaccines and Related Biological Products Advisory Committee – 12/17/2020

The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Moderna, Inc.

#COVID19 #VRBPAC

Category: Health
About The Author
-